Company news
RedHill Biopharma Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
RedHill Biopharma (Nasdaq: RDHL) Highlights Strategic Transformation and Expanded Commercial Growth Strategy in Virtual Investor “What This Means” Segment
November 17, 2026
RedHill Biopharma (Nasdaq: RDHL) Highlights Strategic Transformation and Expanded Commercial Growth Strategy in Virtual Investor "What This Means" Segment
November 17, 2026
Two Leading Labs Confirm RHB-204 MAP-Killing Effect for RedHill's Crohn's Disease Candidate
November 2, 2026
$2.9 Million NCI Grant Awarded for Clinical Development of RedHill's Opaganib and CAR T-Cell Combination in Ultra-High-Risk Multiple Myeloma
October 19, 2026
RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement
December 1, 2025
Calls
- RedHill Biopharma (NASDAQ:RDHL) Q1 2022 Earnings Call
Jun 23, 2022
Transcript - RedHill Biopharma (NASDAQ:RDHL) Q4 2021 Earnings Call
Mar 17, 2022
Transcript - RedHill Biopharma (NASDAQ:RDHL) Q3 2021 Earnings Call
Nov 30, 2021
Transcript - RedHill Biopharma (NASDAQ:RDHL) Q2 2021 Earnings Call
Aug 26, 2021
Transcript - RedHill Biopharma (NASDAQ:RDHL) Q1 2021 Earnings Call
May 27, 2021
Transcript
Decks
The 5 newest of 13 decks. Every deck is listed under its year.
- Investor Presentation (December 2022)
Investor deck · 81 slides · Dec 15, 2022
- Investor Presentation (October 2022)
Investor deck · 77 slides · October 2022
- Investor Presentation (June 2022)
Investor deck · 77 slides · June 2022
- Investor Presentation (April 2022)
Investor deck · 77 slides · Apr 14, 2022
- Q3 2021 Earnings Presentation
Earnings · 46 slides · Nov 30, 2021